Mackenzie, C.; Deluce, J.; Black, M.; Churchman, E.; Winquist, E.; Ernst, S.; Laidley, D.T.; Parezanovic, M.; Potvin, K.; Fernandes, R.
Clinical Outcome Patterns of Use of Radium-223 in Patients with Metastatic Castration-Resistant Prostate Cancer. Curr. Oncol. 2024, 31, 6475-6487.
https://doi.org/10.3390/curroncol31110480
AMA Style
Mackenzie C, Deluce J, Black M, Churchman E, Winquist E, Ernst S, Laidley DT, Parezanovic M, Potvin K, Fernandes R.
Clinical Outcome Patterns of Use of Radium-223 in Patients with Metastatic Castration-Resistant Prostate Cancer. Current Oncology. 2024; 31(11):6475-6487.
https://doi.org/10.3390/curroncol31110480
Chicago/Turabian Style
Mackenzie, Colleen, Jasna Deluce, Morgan Black, Emma Churchman, Eric Winquist, Scott Ernst, David T. Laidley, Matthew Parezanovic, Kylea Potvin, and Ricardo Fernandes.
2024. "Clinical Outcome Patterns of Use of Radium-223 in Patients with Metastatic Castration-Resistant Prostate Cancer" Current Oncology 31, no. 11: 6475-6487.
https://doi.org/10.3390/curroncol31110480
APA Style
Mackenzie, C., Deluce, J., Black, M., Churchman, E., Winquist, E., Ernst, S., Laidley, D. T., Parezanovic, M., Potvin, K., & Fernandes, R.
(2024). Clinical Outcome Patterns of Use of Radium-223 in Patients with Metastatic Castration-Resistant Prostate Cancer. Current Oncology, 31(11), 6475-6487.
https://doi.org/10.3390/curroncol31110480
